NeueHealth, Inc.
NEUE
$5.99
-$0.50-7.70%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 59.50% | 3,447.11% | 504.11% | 122.93% | -96.29% |
| Total Other Revenue | 34.41% | 67.78% | 30.03% | 1,183.49% | 171.02% |
| Total Revenue | 39.32% | 99.53% | 66.27% | 135.48% | -82.07% |
| Cost of Revenue | 48.83% | 87.44% | 44.95% | 138.58% | -85.52% |
| Gross Profit | 4.24% | 184.80% | 2,990.98% | 115.45% | 48.71% |
| SG&A Expenses | 10.96% | -11.03% | -17.84% | 173.60% | -72.38% |
| Depreciation & Amortization | -53.98% | -43.56% | 309.18% | 14.71% | -37.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.96% | 46.80% | 24.33% | 145.02% | -82.06% |
| Operating Income | -5.25% | 67.80% | 53.97% | -565.48% | 82.01% |
| Income Before Tax | -378.72% | 54.66% | 52.81% | -673.08% | 66.01% |
| Income Tax Expenses | -199.53% | -130.72% | -87.39% | 49.04% | 4,558.90% |
| Earnings from Continuing Operations | -359.85% | 57.61% | 55.65% | -549.46% | 64.87% |
| Earnings from Discontinued Operations | 59.11% | 67.75% | -95.67% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -85.71% | -3.72% | 62.00% | -863.43% | -1,084.93% |
| Net Income | -100.07% | 58.92% | 10.36% | 16.57% | -5.38% |
| EBIT | -5.25% | 67.80% | 53.97% | -565.48% | 82.01% |
| EBITDA | -17.18% | 66.51% | 58.68% | -443.35% | 84.27% |
| EPS Basic | -95.32% | 56.54% | 8.86% | 40.05% | -8.72% |
| Normalized Basic EPS | -59.43% | 34.99% | 49.77% | -188.41% | 56.07% |
| EPS Diluted | -95.32% | 56.54% | 8.86% | 40.05% | -8.72% |
| Normalized Diluted EPS | -59.43% | 34.99% | 49.77% | -188.41% | 56.07% |
| Average Basic Shares Outstanding | 1.35% | 1.23% | 0.45% | 60.19% | -0.11% |
| Average Diluted Shares Outstanding | 1.35% | 1.23% | 0.45% | 60.19% | -0.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
